Alamar Biosciences Raises $128 Million in Oversubscribed Series C Financing to Accelerate Commercialization of its Proteomics Platform

Financing led by Sands Capital brings total capital raised to nearly $250 million. FREMONT, Calif., Feb. 26, 2024 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the first close of $100 million in…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks